Navigation Links
Christopher Bowe Joins Scrip as US Healthcare Analyst
Date:9/27/2010

Christopher Bowe Joins Scrip as US Healthcare Analyst -- NEW YORK, September 27, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Publishing & Information Services, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Personnel Announcements Click to view news release full screen  

Christopher Bowe Joins Scrip as US Healthcare Analyst

 

NEW YORK, September 27, 2010 /PRNewswire/ -- Scrip, the market-leading international pharmaceutical and biotech information provider, has appointed Christopher Bowe to the post of US Healthcare Analyst as part of its expansion of an analyst team to serve subscribers.

With his appointment, Bowe will help expand the high-value original and topical analysis of pharmaceutical and healthcare industries, policy and regulation, as well as engage and serve customers through Scrip's tailored project research advisory services of Ask the Analyst. He will be available to media to comment on trends, news and insights derived from original Scrip analysis. His work will cross a diverse constituency ranging from industry, to the financial analyst community, to researchers to communications and consultancy groups.

Christopher joins Scrip and its highly-acclaimed, award-winning news, analysis and data services with more than two decades of experience working in and commentating on the global pharma and biotech industry.

"Christopher has a wealth of industry knowledge and experience and we are delighted that he has joined the analyst team," says Dr Philip Smith, Research Director at Informa, publishers of Scrip. "Our users will benefit from his in-depth knowledge of the US healthcare market gained from extensive experience in the senior journalist roles and more recently, as a senior advisor to top management at a major US pharmaceutical company."

Scrip Intelligence, Clinica MedTech News and the Regulatory Affairs Pharma and Medtech titles will all feature Christopher's content ranging across the North American pharma and medtech sectors and including analysis of current issues in business strategy, policy, regulatory affairs, R&D, technology and company intelligence.

Bowe's appointment also strengthens Scrip's commitment to client research support, which is available through the Ask the Analyst services.

"It is an honour to join the team at Scrip," says Bowe, who will be based in New York, USA. "I look forward to engaging subscribers and providing analysis that leaders and decisionmakers want and need in order to gain competitive insights. The world of healthcare is changing so quickly and original analysis is of high importance.

"I am also very excited about the power of analysis and data through access to the extensive intelligence within the Scrip group," he says.

"Christopher's arrival is an exciting milestone for Scrip's business intelligence services, particularly in the US," continues Dr Smith. "We are setting a new standard in information provision with the recent launch of our cutting-edge SCRIP Intelligence news, analysis and data and Ask the Analyst services. Christopher's experience and knowledge of the industry will help to ensure that the Scrip range of titles remains second-to-none in serving the intelligence needs of those working in and with the global pharma and biotech sectors."

In his most recent role, Christopher served as Counselor, Strategic Affairs for Schering-Plough working directly with CEO Fred Hassan as well as his senior management team. Prior to that, he served as US Healthcare Correspondent and Chicago Correspondent for the Financial Times and as Chicago Correspondent for Dow Jones Newswires.

For more information on Scrip's pharma and medtech intelligence services, please visit the following websites: http://www.scripintelligence.com http://www.clinica.co.uk http://www.rajpharma.com http://www.rajdevices.com
'/>"/>

SOURCE Informa
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
2. Ameristar National Charity Golf Classic Raises More Than $1.1 Million for Buoniconti Fund to Cure Paralysis and Christopher & Dana Reeve Foundation
3. Christopher and Dana Reeve Foundation Response to FDA Clearance of Gerons Clinical Trial
4. VITAS Innovative Hospice Care(R) Names Christopher Rieder Senior Vice President and Chief Information Officer
5. Fina Technologies Names Spotfire Founder Christopher Ahlberg to Board of Directors
6. Christopher Brennan Joins PharmaNet Development Group as General Counsel
7. WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Companys Scientific Advisory Board
8. John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technologys Potential to Help Millions of Patients
9. Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
10. GM Exec Joins Bio-Reaction Industries Board of Directors
11. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Global demand for enzymes is forecast to grow ... billion.  This market includes enzymes used in industrial ... animal feed, and other markets) and specialty applications ... beverages will remain the largest market for enzymes, ... containing enzymes in developing regions.  These and other ...
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... mission to bring innovative medical technologies, services and solutions to the healthcare market. ... and implementation of various distribution, manufacturing, sales and marketing strategies that are necessary ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
(Date:6/22/2016)... -- The American College of Medical Genetics and Genomics was once ... one of the fastest-growing trade shows during the Fastest 50 ... Las Vegas . Winners ... each of the following categories: net square feet of paid ... The 2015 ACMG Annual Meeting was ranked 23 out of ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
Breaking Biology News(10 mins):